Howard Bailey Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558K Buy
465
+5
+1% +$5.11K 0.21% 56
2026
Q1
$423K Sell
460
-6
-1% -$6.08K 0.17% 78
2025
Q4
$501K Buy
+466
New +$446K 0.2% 70
2025
Q3
Sell
-284
Closed -$222K 154
2025
Q2
$222K Hold
284
0.07% 136
2025
Q1
$235K Sell
284
-224
-44% -$186K 0.08% 133
2024
Q4
$392K Sell
508
-72
-12% -$59.6K 0.15% 95
2024
Q3
$514K Buy
+580
New +$521K 0.19% 69

Other funds holding LLY

Howard Bailey Securities's LLY Position: Q2 2026 in Review

Howard Bailey Securities increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $5.11K and bringing the position to 465 shares worth $558K. The position accounts for 0.21% of the portfolio, ranked #56.

Howard Bailey Securities first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Howard Bailey Securities held 465 shares of Eli Lilly worth $558K as of Q2 2026.
  • Howard Bailey Securities bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.21% of Howard Bailey Securities's portfolio in Q2 2026, its #56 holding.
  • Howard Bailey Securities first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Howard Bailey Securities's 13F filing for Q2 2026, filed 10 Aug 2026.